Yoshida Sei | Pharmaceutical Research Division Takeda Chemical Industries

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo
Increased phosphorylation of Akt in triple-negative breast cancers
Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. II. Synthesis and Antitumor Activity of N^5-Substituted Glutamine Analogs

スポンサーリンク